These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 14088565)
21. Decrease of urinary corticosteroids following application of fluocinolone acetonide under an occlusive dressing. SCOGGINS RB J Invest Dermatol; 1962 Dec; 39():473-4. PubMed ID: 13992475 [No Abstract] [Full Text] [Related]
22. THE TOPICAL USE OF FLUOCINOLONE ACETONIDE CREAM FOR RELIEF OF VULVAR AND PERINEAL PRURITUS. ARNO IC; WAPNER PM; BROWNSTEIN IE J Albert Einstein Med Cent (Phila); 1963 Jul; 11():224-7. PubMed ID: 14044068 [No Abstract] [Full Text] [Related]
23. [FLUOCINOLONE ACETONIDE (0.01 PER CENT) UNDER OCCLUSIVE DRESSING: THERAPEUTIC VALUE IN DERMATOLOGY OF THIS NEW PRODUCT IN WEAK CONCENTRATION]. BAZEX A; DUPRE A; CHRISTOL B Presse Med (1893); 1964 Oct; 72():2387-8. PubMed ID: 14187775 [No Abstract] [Full Text] [Related]
28. TOPICAL FLUOCINOLONE WITH OCCLUSION IN PRETIBIAL MYXEDEMA. JONES BE; WILLIAMS RM Arch Dermatol; 1964 Sep; 90():305-6. PubMed ID: 14170604 [No Abstract] [Full Text] [Related]
29. [Quality control of prepared drug forms containing corticosteroids by physicochemical means. II. Spectrophotmetric determination of prednisolone and fluocinolone acetonide in ointments]. Bobkova LN; Kazarinov NA Farm Zh; 1974; (1):59-63. PubMed ID: 4463033 [No Abstract] [Full Text] [Related]
30. [CORTICOSTEROID DRUGS AND CUTANEOUS REACTIVITY. EXPERIMENTAL RESEARCH. I. TOPICAL CORTICOSTEROIDS AND PHARMACODYNAMIC REACTION]. MARTINA G; GRASSO R Minerva Dermatol; 1965 Jan; 40():18-21. PubMed ID: 14306915 [No Abstract] [Full Text] [Related]
31. Mometasone furoate ointment and cream 0.1 percent in treatment of psoriasis: comparison with ointment and cream formulations of fluocinolone acetonide 0.025 percent and triamcinolone acetonide 0.1 percent. Medansky RS; Bressinck R; Cole GW; Deeken JH; Ellis CN; Guin JD; Herndon JH; Lasser AE; Leibsohn E; Menter MA Cutis; 1988 Nov; 42(5):480-5. PubMed ID: 3058398 [TBL] [Abstract][Full Text] [Related]
33. STEROIDS IN THE TREATMENT OF DERMATOSES. GOLDBERG LC Cinci J Med; 1963 Nov; 44():441-3. PubMed ID: 14084718 [No Abstract] [Full Text] [Related]
34. [DEVELOPMENTS IN LOCAL CORTICOSTEROID THERAPY]. LOFFERER O; GARBSCH E Med Welt; 1964 May; 18():1015-9. PubMed ID: 14237027 [No Abstract] [Full Text] [Related]
35. [THE TOPICAL USE OF CORTICOSTEROIDS IN DERMATOLOGY]. POLANO MK Ned Tijdschr Geneeskd; 1965 Jan; 109():180-5. PubMed ID: 14301860 [No Abstract] [Full Text] [Related]
36. [RESULTS OF TREATMENT OF DIFFERENT DERMATOPATHIES WITH FLUOCINOLONE ACETONIDE 0.01 PERCENT AND AN OCCLUSIVE DRESSING]. GERMESLEAL O Medicina (Mex); 1964 Feb; 44():85-91. PubMed ID: 14143140 [No Abstract] [Full Text] [Related]
37. Chemical stability of fluocinolone acetonide ointment and fluocinonide cream diluted in emollient bases. Barnes AR; Chapman SB; Irwin WJ J Clin Pharm Ther; 1995 Oct; 20(5):265-9. PubMed ID: 8576293 [TBL] [Abstract][Full Text] [Related]
38. [Clinical evaluation of the therapeutic activity of a fluocinolone acetonide ointment]. Pochy-Riano' R Omnia Med Ther; 1968; 46(4):849-57. PubMed ID: 4247010 [No Abstract] [Full Text] [Related]
39. [Topical treatment of dermatoses with difluocortolone valerate fatty ointment]. Carvajal Rosado VM Z Hautkr; 1976; 51 Suppl 1():27-9. PubMed ID: 795183 [TBL] [Abstract][Full Text] [Related]
40. CURRENT CONCEPTS IN THE DIAGNOSIS AND TREATMENT OF PSORIASIS. FARBER EM; ROTH RJ GP; 1964 Jun; 29():94-9. PubMed ID: 14143830 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]